Cannara Biotech has received its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham Facility, in Québec.
"Cultivation is expected to begin immediately with a first harvest to take place in the second quarter of 2020," the team with the company explains. "The granted cultivation and processing licences are for Phase 1 of the Farnham Facility (170,000 sq. ft.). The licenced area is part of a larger 625,000 sq. ft. multipurpose and modern facility. Phase 1 includes a designated space for state-of-the-art extraction and processing. Additionally, 100 local jobs will be created, and annual cultivation capacity is estimated at up to 20,000 kg per year."
"After many months of diligent preparation, today's milestone will allow us to start cultivation immediately and to advance our goal of becoming the premiere grower of cannabis in Québec and in due course, the rest of Canada," said Barry Laxer, COO of Cannara Biotech (Quebec) Inc. "All of us would like to thank our construction team for delivering a state-of-the-art facility, along with the invaluable community support we have received. With a well-funded balance sheet, financially Cannara begins this next phase of our growth with strength and durable fundamentals," added Mr. Laxer.
For more information:
Cannara Biotech
Lennie Ryer, CPA, CA, CFO
514-543-4200 Ext. 253
lennie@cannara.ca
cannara.ca